Explore
Medicinehospital

Urokinase

Clot-dissolving enzyme infusion for pulmonary embolism.

Clinical information

Common uses

  • dissolving blood clots in the lungs (pulmonary embolism)

Cautions

  • increases fibrinolytic (clot-breaking) activity for hours after infusion
  • made from cultured human cells — screened for infections
  • best results when started within days of clot onset

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Kinlytic (urokinase) injection label, setid bfe5cfb9-591d-4df8-12a3-6555cde3185d (accessed 2026-08-16)

Approved brands & formulations3

Brand nameDosage formStrengthImporterCategory
UrokinaseParenteral ( Injection )5000IUMFDA designated importers with Pre Authorization approval before importhospital
UrokinaseParenteral ( Injection )250000 IU/vialMFDA designated importers with Pre Authorization approval before importhospital
UrokinaseParenteral ( Injection )500000 IU/vialMFDA designated importers with Pre Authorization approval before importhospital
Old search API